학술논문
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas
Document Type
Article
Author
Source
In: Cancers . (Cancers, March 2023, 15(6))
Subject
Language
English
ISSN
20726694